Cancers | Highly Cited Papers and Hot Topic Special Issues on Anti-cancer Research
We are delighted to share some highly cited papers on anti-cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.
“Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives”
by Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Aigner and Thomas Büch
Cancers 2021, 13(4), 634; https://doi.org/10.3390/cancers13040634
Available online: https://www.mdpi.com/2072-6694/13/4/634
“3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs”
by Mélanie A. G. Barbosa, Cristina P. R. Xavier, Rúben F. Pereira, Vilma Petrikaitė and M. Helena Vasconcelos
Cancers 2022, 14(1), 190; https://doi.org/10.3390/cancers14010190
Available online: https://www.mdpi.com/2072-6694/14/1/190
“Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin”
by Esra Küpeli Akkol, Iffet Irem Tatlı, Gökçe Şeker Karatoprak, Osman Tuncay Ağar, Çiğdem Yücel, Eduardo Sobarzo-Sánchez and Raffaele Capasso
Cancers 2021, 13(11), 2733; https://doi.org/10.3390/cancers13112733
Available online: https://www.mdpi.com/2072-6694/13/11/2733
“Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update”
by Jen-Fu Hsu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang and Ming-Horng Tsai
Cancers 2021, 13(2), 195; https://doi.org/10.3390/cancers13020195
Available online: https://www.mdpi.com/2072-6694/13/2/195
“Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review”
by Sareh Kamran, Ajantha Sinniah, Mahfoudh A. M. Abdulghani and Mohammed Abdullah Alshawsh
Cancers 2022, 14(5), 1100; https://doi.org/10.3390/cancers14051100
Available online: https://www.mdpi.com/2072-6694/14/5/1100
“The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions”
by Tadeusz Robak, Magda Witkowska and Piotr Smolewski
Cancers 2022, 14(3), 771; https://doi.org/10.3390/cancers14030771
Available online: https://www.mdpi.com/2072-6694/14/3/771
“The Renaissance of Cyclin Dependent Kinase Inhibitors”
by Tobias Ettl, Daniela Schulz and Richard Josef Bauer
Cancers 2022, 14(2), 293; https://doi.org/10.3390/cancers14020293
Available online: https://www.mdpi.com/2072-6694/14/2/293
|
“Cancer Cell Metabolism and Drug Targets” Edited by: Dr. Daniel S. Sitar and Prof. Dr. Donald Miller
|
“Drug Resistance in Gastrointestinal Cancer” Edited by: Dr. Rosalba D’Alessandro and Dr. Carmelo Ferrai |
|
“Anticancer Drugs: Recent Advances and Challenges” Edited by: Dr. Moutih Rafei and Dr. Sebastien Talbot
|
“Drug Development for Acute Lymphoblastic Leukemia” Edited by: Dr. Rajesh Ramakrishnan Nair
|
We hope this announcement will provide useful information for this field.